Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4295 results

Sort By:

Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora

Study ID: NCT03463239
Start Date: 2025-01
End Date: 2025-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

10

Intervention / Treatment

Autologous tissue engineered corpora

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Study ID: NCT06236139
Start Date: 2024-12-01
End Date: 2027-03-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

Anti-STEAP1 CAR T-cells

Biopsy

Biospecimen Collection

Bone Scan

Computed Tomography

Cyclophosphamide

Echocardiography

Enzalutamide

Fludarabine

Leukapheresis

Magnetic Resonance Imaging

Multigated Acquisition Scan

Positron Emission Tomography

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Australian National Vulvar Cancer Trial

Study ID: NCT06476639
Start Date: 2025-04
End Date: 2029-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

240

Intervention / Treatment

High-resolution bilateral groin ultrasound monitoring

Sponsor

Queensland Centre for Gynaecological Cancer

Source: clinicaltrials.gov

Share:
Add to list

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

Study ID: NCT06610539
Start Date: 2024-12
End Date: 2028-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

184

Intervention / Treatment
Sponsor

Endomagnetics Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Acute Effect of Local Vibration in Stroke Patients

Study ID: NCT06610994
Start Date: 2024-12-01
End Date: 2025-12-20
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

local vibration apply

Sponsor

Kırıkkale University

Source: clinicaltrials.gov

Share:
Add to list

Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With Relapsed or Refractory B-Cell Neoplasms

Study ID: NCT06508931
Start Date: 2025-04-01
End Date: 2029-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

31

Intervention / Treatment

zamtocabtagene autoleucel (MB-CART2019.1)

Sponsor

Miltenyi Biomedicine GmbH

Source: clinicaltrials.gov

Share:
Add to list

Extending Outcomes for Pancreas Cancer Patients with Nominal Oligometastatic Disease (EXPAND): a Randomized Phase III Trial

Study ID: NCT06593431
Start Date: 2024-12-31
End Date: 2029-06-29
Study Type

Interventional

Study Phase

Phase3

No. of Participants

80

Intervention / Treatment

Consolidative Radiation

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

MyStroke for Stroke Survivors and Caregivers

Study ID: NCT06442631
Start Date: 2025-07-01
End Date: 2029-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

586

Intervention / Treatment

MyStroke

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

COPEWeb Training for Providers

Study ID: NCT05812131
Start Date: 2025-01-01
End Date: 2027-04-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

248

Intervention / Treatment

COPEWeb online training

COPE In Person

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Inflammatory Challenge in Human Aggression.

Study ID: NCT06665074
Start Date: 2025-01
End Date: 2030-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

112

Intervention / Treatment

Endotoxin (E. coli O:113, Reference Endotoxin)

Saline (Placebo)

Sponsor

Ohio State University

Source: clinicaltrials.gov

Share:
Add to list